JAMP-MONTELUKAST 10mg recall in Canada: may contain foreign fragments
In plain language
This recall involves JAMP-MONTELUKAST 10mg tablets sold in Canada. It's being recalled because the affected lot may contain foreign fragments of pink candesartan tablets. Consult your healthcare provider before stopping use and follow the steps in the official notice.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use.
- Contact JAMP Pharma Corporation if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP-MONTELUKAST 10mg
Lot: AT240486A
Why this matters
Contamination
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: AT240486A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Contamination
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact JAMP Pharma Corporation if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Contamination
When was this product recalled?
This product was recalled on April 24, 2025.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves JAMP-MONTELUKAST 10mg tablets sold in Canada. It's being recalled because the affected lot may contain foreign fragments of pink candesartan tablets. Consult your healthcare provider before stopping use and follow the steps in the official notice.